» Authors » Wen-Hsiang Lee

Wen-Hsiang Lee

Explore the profile of Wen-Hsiang Lee including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 290
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Lee W, Joshi P, Wen R
Adv Exp Med Biol . 2014 Mar; 801:23-30. PMID: 24664677
Background And Aims: Glutathione S-transferase pi isoform (GSTP1) is an intracellular detoxification enzyme that catalyzes reduction of chemically reactive electrophiles and is a zeaxanthin-binding protein in the human macula. We...
12.
Schwartz S, Flynn Jr H, Lee W, Wang X
Cochrane Database Syst Rev . 2014 Feb; (2):CD006126. PMID: 24532038
Background: Retinal detachment (RD) with proliferative vitreoretinopathy (PVR) often requires surgery to restore normal anatomy and to stabilize or improve vision. PVR usually occurs in association with recurrent RD (that...
13.
Chen R, Flynn Jr H, Lee W, Parke 3rd D, Isom R, Davis J, et al.
Am J Ophthalmol . 2014 Jan; 157(4):870-875.e1. PMID: 24384527
Purpose: To report the outcomes of current vitreoretinal surgical management of proliferative sickle retinopathy and to compare current methods to previous studies. Design: A retrospective, interventional case series. Methods: Fifteen...
14.
Moshfeghi A, Rosenfeld P, Flynn Jr H, Schwartz S, Davis J, Murray T, et al.
Retina . 2011 Aug; 31(4):662-8. PMID: 21836400
Purpose: To assess the rate of infectious endophthalmitis and to describe the clinical and microbiological features of eyes that develop clinically suspected endophthalmitis after an intravitreal injection of vascular endothelial...
15.
Schwartz S, Flynn Jr H, Lee W, Ssemanda E, Ervin A
Cochrane Database Syst Rev . 2009 Oct; (4):CD006126. PMID: 19821354
Background: Retinal detachment (RD) with proliferative vitreoretinopathy (PVR) often requires surgery. During surgery, a tamponade agent is needed to reduce the rate of recurrent retinal detachment. Objectives: The objective of...
16.
Stepien K, Rosenfeld P, Puliafito C, Feuer W, Shi W, Al-Attar L, et al.
Retina . 2009 Aug; 29(8):1067-73. PMID: 19696701
Purpose: To compare outcomes after switching from intravitreal bevacizumab (Avastin) to ranibizumab (Lucentis) in patients with neovascular age-related macular degeneration (AMD). Methods: A retrospective review was performed of patients with...
17.
Gregori N, Rattan G, Rosenfeld P, Puliafito C, Feuer W, Flynn Jr H, et al.
Retina . 2009 Jul; 29(7):913-25. PMID: 19584649
Purpose: To evaluate the safety and efficacy of intravitreal bevacizumab (Avastin, Genentech) for the treatment of macular edema (ME) secondary to branch retinal vein occlusion (BRVO) and hemiretinal vein occlusion...
18.
Gregori N, Gaitan J, Rosenfeld P, Puliafito C, Feuer W, Flynn Jr H, et al.
Retina . 2009 May; 28(9):1325-37. PMID: 19430392
Purpose: To evaluate the long-term safety and efficacy of intravitreal bevacizumab injections (Avastin, Genentech Inc., San Francisco, CA) for the treatment of macular edema secondary to central retinal vein occlusions....
19.
Nagai N, Klimava A, Lee W, Izumi-Nagai K, Handa J
Invest Ophthalmol Vis Sci . 2008 Nov; 50(4):1903-10. PMID: 19011018
Purpose: Matrix expansion is an early change in age-related maculopathy. The aim of this study was to determine whether connective tissue growth factor (CTGF) regulates the production of extracellular matrix...
20.
Lai M, Lai J, Lee W, Huang J, Patel S, Ying H, et al.
Ophthalmology . 2005 Apr; 112(4):574-9. PMID: 15808246
Objective: To compare the efficacy and efficiency of retrobulbar versus sub-Tenon's capsule injection of local anesthetic in vitreoretinal surgery. Design: Prospective, randomized, double-masked clinical trial. Participants And Intervention: Sixty-four eyes...